Hims & Hers Health, Inc. (HIMS) News

Hims & Hers Health, Inc. (HIMS): $7.89

-0.43 (-5.17%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter HIMS News Items

HIMS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HIMS News Highlights

  • For HIMS, its 30 day story count is now at 4.
  • Over the past 6 days, the trend for HIMS's stories per day has been choppy and unclear. It has oscillated between 2 and 2.

Latest HIMS News From Around the Web

Below are the latest news stories about HIMS & HERS HEALTH INC that investors may wish to consider to help them evaluate HIMS as an investment opportunity.

Hims & Hers Health: Buy Into The Strong Growth Momentum (NYSE:HIMS)

Hims & Hers Health offers a telehealth platform that connects patients with doctors across various specialties. Find out why I recommend going long HIMS stock.

Seeking Alpha | January 18, 2023

Hims & Hers Launches New Line of Volumizing Shampoos and Conditioners

SAN FRANCISCO, January 18, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, is today announcing a new line of thoughtfully crafted volumizing shampoos and conditioners that are formulated with Biovolume 128™, which has been shown to increase hair volume. These vegan, paraben-, phthalates-, sulfate-, dye- and cruelty-free formulas have been developed specifically t

Yahoo | January 18, 2023

Kristen Bell Partners With Hers As Its First Mental Health Ambassador

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, announced today that actress Kristen Bell is joining Hers as its first Mental Health Ambassador. Sharing a common goal of helping people feel confident when it comes to taking care of their mental health, Bell and Hers

Wallstreet:Online | January 12, 2023

Devon Energy And Hims & Hers Health - Raul Shah''s Hot Take

Investing Experts Podcast''s guest of this week is Raul Shah. Raul discusses why he is a shareholder of Hims & Hers Health (HIMS) and Devon Energy (DVN).

Seeking Alpha | January 5, 2023

Hims & Hers Health: The Ultimate Pick For 2023 (NYSE:HIMS)

Hims & Hers Health is a telehealth company which solves two major issues for patients in modern healthcare. Click here to read why it''s my top pick for 2023.

Seeking Alpha | December 23, 2022

Hims & Hers Welcomes Back Dr. Pat Carroll as Chief Medical Officer

SAN FRANCISCO, December 20, 2022--Hims & Hers Health, Inc. ("Hims & Hers," NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced the return of Dr. Pat Carroll as Chief Medical Officer. Dr. Carroll rejoins Hims & Hers to redouble the company’s focused clinical operations, which ensure every consumer on the platform receives the highest-quality care.

Yahoo | December 20, 2022

Hims & Hers Health: The Unicorn (Former) SPAC For 2023 (NYSE:HIMS)

Hims & Hers Health, Inc. blew their original 2022 financial projections out of the water and is a growth investor''s dream. Click here to learn more about HIMS.

Seeking Alpha | December 16, 2022

Hims & Hers Health Seems Like A Great Pick For 2023 (NYSE:HIMS)

Hims & Hers Health has demonstrated resilient margins and accelerating growth in 2022. Read more to know why HIMS stock is a great pick for 2023.

Seeking Alpha | December 10, 2022

Have you been able to find a good deal on Hims & Hers Health Inc.’s shares?

In Tuesday’s session, Hims & Hers Health Inc. (NYSE:HIMS) marked $6.62 per share, down from $6.71 in the previous session. While Hims & Hers Health Inc. has underperformed by -1.34%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HIMS rose by 9.97%, with highs and lows […]

US Post News | December 7, 2022

Hims & Hers appoints first-ever Chief Pharmacy & Innovation Officer

SAN FRANCISCO, December 05, 2022--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today made a key leadership appointment, naming pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the company’s first-ever Chief Pharmacy & Innovation Officer.

Yahoo | December 5, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5984 seconds.